2025-09-18T12:52:52-05:00 2024-12-31 221732349 WISS & COMPANY LLP 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 990 2024-01-01 832388861 GLIOBLASTOMA RESEARCH ORGANIZATION INC GLIO 3059848164 2045 BISCAYNE BLVD 189 MIAMI FL 33137 AMBER BARBACH FOUNDER AND CEO 3059848164 2025-09-17 1 1 DIANA MILLER P01597612 9739949400 2024 2025-03-06 01:10:19Z AMBER BARBACH 2045 BISCAYNE BLVD 189 MIAMI FL 33137 1185650 0 X WWW.GBMRESEARCH.ORG X 2018 NY RAISING AWARENESS AND FUNDS FOR NEW GLOBAL, CUTTING-EDGE RESEARCH TO HELP FIND A CURE FOR GLIOBLASTOMA. 6 3 5 20 0 0 826259 1085196 0 0 0 3270 5746 -63222 832005 1025244 104000 195000 0 0 139552 246800 0 0 112745 236709 365976 480261 807776 351744 217468 492941 728675 6738 25004 486203 703671 X GLIOBLASTOMA RESEARCH ORGANIZATION, INC. IS A 501(C)(3) NONPROFIT ORGANIZATION THAT RAISES AWARENESS AND FUNDS FOR NEW GLOBAL, CUTTING-EDGE RESEARCH TO HELP FIND A CURE FOR GLIOBLASTOMA. 0 0 565812 195000 0 SEE SCHEDULE O FOR DETAIL. THE ORGANIZATION TO DATE, HAS PROVIDED SUPPORT TO DOCTORS AND RESEARCHERS THROUGH THIRTEEN FULLY FUNDED PROJECTS AT U.S. BASED LEADING CANCER CENTERS. THE ORGANIZATION, ALSO DONATED OVER $600,000 IN THE LAST FEW YEARS AND HAS PARTNERED WITH GBM-RELATED PROJECTS AROUND THE GLOBE. THE ORGANIZATION HAS THE OPPORTUNITY TO MEET WITH LEADERS IN NEURO-ONCOLOGY AS WELL AS CONNECT WITH THE PEOPLE AND FAMILIES DIRECTLY IMPACTED BY GLIOBLASTOMA. THE STORIES BEHIND THIS DEADLY CANCER DRIVE OUR RESEARCH FUNDING MISSION. FUELED BY OUR FOUNDER'S PERSONAL EXPERIENCE WITH GBM, THE GLIOBLASTOMA RESEARCH ORGANIZATION'S COMMUNICATIONS CHANNELS, SUCH AS SOCIAL MEDIA, SERVE AS A BRIDGE TO CONNECT THOSE ALL OVER THE WORLD WHO ARE SUFFERING FROM GLIOBLASTOMA OR HAVE BEEN AFFECTED BY THE DISEASE. THE ORGANIZATION PROVIDES A HUB FOR COMMUNICATION WHERE PEOPLE IN THE SAME SITUATION CAN SHARE THEIR EXPERIENCES. 16610 SEE SCHEDULE O FOR DETAIL. THE ORGANIZATION HAS ESTABLISHED OVER 15 UNIQUE CAMPAIGNS, TO CONTINUE ITS ADVOCACY WORK, TO SHARE THE STORIES OF PATIENTS AND CAREGIVERS DEALING WITH BRAIN CANCER IN ONE WAY OR ANOTHER. THE GLIOBLASTOMA AKA GBM PODCAST, IN WHICH THE HOST HAS MEANINGFUL AND INSIGHTFUL CHATS WITH MEDICAL PROFESSIONALS, PATIENTS, CAREGIVERS, AND BIOTECH COMPANIES - TO FURTHER AWARENESS AND PROVIDE ANOTHER OUTLET FOR COMMUNITIES TO LEARN ABOUT BRAIN CANCER, IS NOW GOING INTO ITS THIRD SEASON WITH OVER 75,000 DOWNLOADS SINCE CREATION. 582422 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 17 0 1 5 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 6 3 1 0 0 0 0 0 0 1 0 0 0 1 1 1 1 1 1 1 1 0 NY FL X X AMBER BARBACH 3059848164 2045 BISCAYNE BLVD 189 MIAMI FL 33137 AMBER BARBACH FOUNDER AND EXECUTIVE DIRECTOR 60.00 X X 105237 0 512 ELISSA BARBACH VICE PRESIDENT 20.00 X X 11638 0 0 KYLIE BARNES SECRETARY 1.00 X X 0 0 0 MARVIN LEW DIRECTOR 10.00 X 0 0 0 KATHERINE SNEDEKER DIRECTOR 10.00 X 20000 0 0 YONATAN BARDASH DIRECTOR 1.00 X 0 0 0 136875 0 512 1 0 0 0 0 231420 853776 24737 1085196 3270 3270 14186 14186 0 0 63520 231420 135948 -72428 -72428 19478 10272 9206 9206 1025244 0 0 -59952 X 195000 195000 137387 107314 4663 25410 91393 71655 2772 16966 18020 14112 560 3348 19555 6586 12969 38505 12969 25536 94786 44304 12851 37631 64327 45206 2833 16288 25743 21326 4417 20271 20271 1110 884 226 45438 38894 6544 9665 6359 3306 566 566 GIFTS 17387 17387 PODCASTS 16610 16610 OTHER FUNDRAISING EXPEN 8459 8459 DOCUMENTARY EXPENSE 3142 3142 412 412 807776 582422 112609 112745 393677 75767 5295 598566 67722 19918 12927 33763 1698 1037 1227 661 12093 0 492941 728675 6738 14549 10455 6738 25004 X 486203 703671 486203 703671 492941 728675 217468 0 X 0 1 X 0 0 X 121490 189363 281358 826259 1085196 2503666 121490 189363 281358 826259 1085196 2503666 2503666 318 1 3270 3589 21796 63520 85316 2592571 53770 0.96570 0.98510 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: FUNDRAISING REVENUE - 2023 AMOUNT: $ 21,796. 2024 AMOUNT: $ 63,520. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1698 1037 661 661 X 1214952 62966 62966 1151986 -126742 -126742 1025244 997484 62966 126742 189708 807776 0 807776 PART X, LINE 2: THE ORGANIZATION IS ORGANIZED AS A NEW YORK NONPROFIT CORPORATION AND HAS BEEN RECOGNIZED BY THE IRS AS EXEMPT FROM FEDERAL INCOME TAXES UNDER IRC SECTION 501(A) AS AN ORGANIZATION DESCRIBED IN IRC SECTION 501(C)(3), QUALIFIES FOR THE CHARITABLE CONTRIBUTION DEDUCTION, AND HAS BEEN DETERMINED NOT TO BE A PRIVATE FOUNDATION. THE ORGANIZATION IS ANNUALLY REQUIRED TO FILE A RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX (FORM 990) WITH THE IRS. IN ADDITION, THE ORGANIZATION IS SUBJECT TO INCOME TAX ON NET INCOME THAT IS DERIVED FROM BUSINESS ACTIVITIES THAT ARE UNRELATED TO THE ORGANIZATION'S EXEMPT PURPOSES. MANAGEMENT HAS DETERMINED THAT THE ORGANIZATION IS NOT SUBJECT TO UNRELATED BUSINESS INCOME TAX AND HAS NOT FILED AN EXEMPT ORGANIZATION BUSINESS INCOME TAX RETURN (FORM 990-T) WITH THE IRS. MANAGEMENT HAS ANALYZED THE TAX POSITIONS TAKEN BY THE ORGANIZATION AND HAS CONCLUDED THAT AS OF DECEMBER 31, 2024, THERE ARE NO UNCERTAIN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN. MANAGEMENT BELIEVES IT IS NO LONGER SUBJECT TO FEDERAL AND STATE INCOME TAX EXAMINATIONS FOR YEARS PRIOR TO 2022. PART XI, LINE 4B - OTHER ADJUSTMENTS: RECLASS - FUNDRAISING EVENT EXPENSES -135,948. RECLASS - MERCHANDISE SALES 19,478. RECLASS - COST OF GOODS SOLD -10,272. PART XII, LINE 2D - OTHER ADJUSTMENTS: RECLASS - FUNDRAISING EVENT EXPENSES 135,948. RECLASS - MERCHANDISE SALES -19,478. RECLASS - COST OF GOODS SOLD 10,272. GLIOBLASTOMA SUMMIT 67035 56000 11035 36750 14935 36956 5K YOUR WAY 186433 147916 38517 13622 2 41472 27504 13968 2943 2000 28742 294940 231420 63520 39693 16935 79320 135948 -72428 1 CHILDRENS HOSPITAL LOS ANGELES 4650 SUNSET BOULEVARD LOS ANGELES CA 90027 951690977 501(C)(3) 50000 0 TO SUPPORT GLIOBLASTOMA RESEARCH. CHILDREN'S NATIONAL MEDICAL CENTER 111 MICHIGAN AVE NW WASHINGTON DC 20010 521640403 501(C)(3) 80000 0 TO SUPPORT GLIOBLASTOMA RESEARCH. DUKE UNIVERSITY 2200 W MAIN ST STE 300 DURHAM NC 27705 560532129 501(C)(3) 35000 0 TO SUPPORT GLIOBLASTOMA RESEARCH. HEALTH RESEARCH ALLIANCE 3110 EDWARDS MILL RD 300 RALEIGH NC 27612 680617198 501(C)(3) 25000 0 TO SUPPORT GLIOBLASTOMA RESEARCH. 4 0 PART I, LINE 2: GRANTS ARE REVIEWED ANNUALLY AND ADJUSTED WHEN INDICATED BY CHANGES IN CIRCUMSTANCES AND/OR THE ORGANIZATION'S OVERALL BUDGET CONSIDERATIONS. FORM 990, PART VI, SECTION A, LINE 2 THE FOLLOWING BOARD MEMBERS HAVE A FAMILY RELATIONSHIP: 1. AMBER BARBACH AND ELISSA BARBACH 2. AMBER BARBACH AND MARVIN LEW 3. MARVIN LEW AND ELISSA BARBACH FORM 990, PART VI, SECTION A, LINE 8B THERE IS NO COMMITTEE WITH AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY. FORM 990, PART VI, SECTION B, LINE 11B A COPY OF THE FORM 990 IS PROVIDED TO ALL BOARD MEMBERS. THE FORM 990 IS REVIEWED BY THE EXECUTIVE DIRECTOR, AMBER BARBACH AND ALL COMMENTS ARE DIRECTED TO THE PREPARER BEFORE IT IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C PRIOR TO ELECTION DIRECTORS SHALL AND EACH COVERED PERSON ANNUALLY SHALL SIGN A STATEMENT THAT CONFIRMS SUCH COVERED PERSON: A. HAS RECEIVED A COPY OF THE CONFLICT OF INTEREST POLICY; B. HAS READ AND UNDERSTANDS THE POLICY; C. HAS AGREED TO COMPLY WITH THE POLICY; AND D. UNDERSTANDS THAT THE ORGANIZATION IS A TAX EXEMPT ORGANIZATION AND THAT IN ORDER TO MAINTAIN ITS FEDERAL TAX EXEMPTION IT MUST ENGAGE PRIMARILY IN ACTIVITIES WHICH ACCOMPLISH ONE OR MORE OF ITS TAX-EXEMPT PURPOSES. IN ADDITION, TO ENSURE THE ORGANIZATION OPERATES IN A MANNER CONSISTENT WITH TAX EXEMPT PURPOSES AND DOES NOT ENGAGE IN ACTIVITIES THAT COULD JEOPARDIZE ITS TAX-EXEMPT STATUS, PERIODIC REVIEWS SHALL BE CONDUCTED. THE PERIODIC REVIEWS SHALL, AT A MINIMUM, INCLUDE THE FOLLOWING SUBJECTS: A. WHETHER COMPENSATION ARRANGEMENTS AND BENEFITS ARE REASONABLE, BASED ON COMPETENT SURVEY INFORMATION, AND THE RESULT OF ARM'S LENGTH BARGAINING; AND B. WHETHER PARTNERSHIPS, JOINT VENTURES, AND ARRANGEMENTS WITH MANAGEMENT ORGANIZATIONS CONFORM TO THE ORGANIZATION'S WRITTEN POLICIES, ARE PROPERLY RECORDED, REFLECT REASONABLE INVESTMENT OR PAYMENTS FOR GOODS AND SERVICES, FURTHER TAX EXEMPT PURPOSES AND DO NOT RESULT IN INUREMENT, IMPERMISSIBLE PRIVATE BENEFIT OR AN EXCESS BENEFIT TRANSACTION. FORM 990, PART VI, SECTION B, LINE 15 COMPENSATION IS DECIDED UPON BY THE FULL BOARD OF DIRECTORS, BASED ON MARKET RESEARCH AND SALARY INFORMATION AT COMPARABLE ORGANIZATIONS. FORM 990, PART VI, SECTION C, LINE 18 FORM 990 AVAILABLE UPON REQUEST. FORM 990 IS ALSO AVAILABLE ON THE IRS WEBSITE - HTTPS://APPS.IRS.GOV/APP/EOS/ AND GUIDESTAR.COM FORM 990, PART VI, SECTION C, LINE 19 FINANCIAL STATEMENTS, GOVERNING DOCUMENTS AND POLICIES ARE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G BANK AND MERCHANT FEES: PROGRAM SERVICE EXPENSES 2,402. MANAGEMENT AND GENERAL EXPENSES 1,396. FUNDRAISING EXPENSES 37,631. TOTAL EXPENSES 41,429. OFFICE ASSISTANT: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 11,455. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 11,455. COMMUNITY DEVELOPMENT: PROGRAM SERVICE EXPENSES 41,902. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 41,902.